Simufilam advancing towards a clinical study expected to begin in H1 2026 for the potential treatment of TSC-related epilepsyFurther fortified ...

Meg Alexander appointed Chief Executive Officer effective January 1, 2026; Dr. Jeremy M. Levin to transition to Executive Chair of the Board of ...

Getting a driver's license in the U.S. is fairly easy, but that's not the case everywhere. These are the most difficult ...

The Korea Financial Investment Association said on the 31st that as SK hynix’s market cap weight has exceeded 10% of the ...

Meg Alexander appointed Chief Executive Officer effective January 1, 2026; Dr. Jeremy M. Levin to transition to Executive Chair of the Board of DirectorsNext-generation GABA-aminotransferase (GABA-AT) ...

Q3 2025 Earnings Call Transcript November 5, 2025 LivaNova PLC misses on earnings expectations. Reported EPS is $0.4855 EPS, ...

A disabled man says he walked out of a Liverpool city centre pub in tears. Peter Hogan has frequented Tess Riley's on Great Charlotte Street near Liverpool Central for "many years" however, the ...

Good day, ladies and gentlemen, and welcome to LivaNova plc Third Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded. I'd now like to ...

Researchers from the University of Rochester and Harvard Medical School developed a nano-micelle CBD formulation that rapidly ...

ClearPoint Neuro, Inc. ( CLPT) Q3 2025 Earnings Call November 6, 2025 5:00 PM EST [Audio Gap] comments made on this call may include statements that are forward-looking within the meaning of ...

LivaNova PLC (LIVN) reports robust growth in cardiopulmonary and epilepsy segments, but faces challenges with margins and ...

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today hosted its 2025 Investor Day and presented its comprehensive strategic roadmap and long-range financial plan.